Tenax Therapeutics (TENX) Receivables (2016 - 2017)
Historic Receivables for Tenax Therapeutics (TENX) over the last 7 years, with Q3 2017 value amounting to $24649.0.
- Tenax Therapeutics' Receivables fell 6604.82% to $24649.0 in Q3 2017 from the same period last year, while for Sep 2017 it was $24649.0, marking a year-over-year decrease of 6604.82%. This contributed to the annual value of $72599.0 for FY2016, which is N/A changed from last year.
- As of Q3 2017, Tenax Therapeutics' Receivables stood at $24649.0, which was down 6604.82% from $24649.0 recorded in Q2 2017.
- In the past 5 years, Tenax Therapeutics' Receivables registered a high of $541463.0 during Q2 2013, and its lowest value of $24648.0 during Q2 2016.
- Over the past 5 years, Tenax Therapeutics' median Receivables value was $66108.0 (recorded in 2014), while the average stood at $93660.3.
- As far as peak fluctuations go, Tenax Therapeutics' Receivables soared by 100423.78% in 2013, and later crashed by 8779.09% in 2014.
- Quarter analysis of 5 years shows Tenax Therapeutics' Receivables stood at $123873.0 in 2013, then tumbled by 70.65% to $36358.0 in 2014, then soared by 36.0% to $49448.0 in 2015, then surged by 46.82% to $72599.0 in 2016, then tumbled by 66.05% to $24649.0 in 2017.
- Its last three reported values are $24649.0 in Q3 2017, $24649.0 for Q2 2017, and $24649.0 during Q1 2017.